Literature DB >> 29602577

Does multimorbidity still remain a matter of the elderly: Lithuanian national data analysis.

E Jurevičienė1, G Onder2, Ž Visockienė1, R Puronaitė3, D Petrikonytė1, U Gargalskaitė1, V Kasiulevičius1, R Navickas4.   

Abstract

INTRODUCTION: Multimorbidity - the coexistence of ≥2 chronic conditions in same individual is usually associated with older age. There is an increase in its prevalence at a much younger age, however with very limited research specifying that.
OBJECTIVE: To identify age breaking points for the occurrence of multimorbidity.
METHODS: The study included patients, who used any healthcare services between the 01/01/2012 and 30/06/2014. Patients were divided into two groups - with single chronic condition and with multimorbidity. Age-specific proportion of multimorbidity, rate of primary and outpatient visits, number of hospitalizations and prescribed reimbursed medications between these groups were analyzed.
RESULTS: The study included 452578 patients, 94.63% of them had more than one chronic condition. The risk increase with every consecutive year for developing multimorbidity was between the age of 28 and 39 years. The age breaking point for the rapid increase in hospitalizations was about 29 years in multimorbidity group. The proportion of patients with multimorbidity using expensive medications starts to increase at the age of 41.
CONCLUSIONS: The risk of acquiring an additional chronic condition rises exponentially from the age of 29 years and platos between the age of 51 and 57. Patients with multimorbidity require increasing amounts of primary healthcare resources, where patients with single chronic condition require decreasing primary care usage, possibly attributed to successful patient empowerment.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Age breaking point; Healthcare resources; Multimorbidity; Patient empowerment

Mesh:

Year:  2018        PMID: 29602577     DOI: 10.1016/j.healthpol.2018.03.003

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  4 in total

1.  Effect of medicines management versus standard care on readmissions in multimorbid patients: a randomised controlled trial.

Authors:  Marianne Lea; Morten Mowé; Espen Molden; Kristin Kvernrød; Eva Skovlund; Liv Mathiesen
Journal:  BMJ Open       Date:  2020-12-29       Impact factor: 2.692

2.  Association between multimorbidity, self-rated health and life satisfaction among independent, community-dwelling very old persons in Japan: longitudinal cohort analysis from the Kawasaki Ageing and Well-being Project.

Authors:  Takayuki Ando; Yoshinori Nishimoto; Takumi Hirata; Yukiko Abe; Midori Takayama; Takashi Maeno; Seitaro Fujishima; Toru Takebayashi; Yasumichi Arai
Journal:  BMJ Open       Date:  2022-02-24       Impact factor: 2.692

3.  Structure and Distribution of Health Care Costs across Age Groups of Patients with Multimorbidity in Lithuania.

Authors:  Laura Nedzinskienė; Elena Jurevičienė; Žydrūnė Visockienė; Agnė Ulytė; Roma Puronaitė; Vytautas Kasiulevičius; Edita Kazėnaitė; Greta Burneikaitė; Rokas Navickas
Journal:  Int J Environ Res Public Health       Date:  2021-03-09       Impact factor: 3.390

4.  Epidemiology of Chronic Obstructive Pulmonary Disease (COPD) Comorbidities in Lithuanian National Database: A Cluster Analysis.

Authors:  Elena Jurevičienė; Greta Burneikaitė; Laimis Dambrauskas; Vytautas Kasiulevičius; Edita Kazėnaitė; Rokas Navickas; Roma Puronaitė; Giedrė Smailytė; Žydrūnė Visockienė; Edvardas Danila
Journal:  Int J Environ Res Public Health       Date:  2022-01-15       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.